Evidence map›Paper›PMID 42449829›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Diabetes Mellitus Prevalence by Uveitis Etiology at a Japanese Tertiary Center.

Kei Wakatsuki, Kinya Tsubota, Masaki Asakage, Chihiro Maehara, Keiko Maruo, Yoshihiko Usui

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kei WakatsukiDepartment of Ophthalmology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.
Kinya TsubotaDepartment of Ophthalmology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.ORCID 0000-0002-7680-3745
Masaki AsakageDepartment of Ophthalmology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.
Chihiro MaeharaDepartment of Ophthalmology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.
Keiko MaruoDepartment of Ophthalmology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.
Yoshihiko UsuiDepartment of Ophthalmology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.ORCID 0000-0002-1258-3587

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus (DM) may influence susceptibility to ocular infection and inflammatory phenotypes; however, disease-specific DM prevalence across uveitis etiologies has not been well characterized. We evaluated DM prevalence across major uveitis entities in a large single-center cohort and compared observed prevalence estimates with age-specific national estimates from Japan. A total of 3163 adult patients out of 4751 patients newly diagnosed with uveitis at the Tokyo Medical University Hospital between 2004 and 2023 were included in the final analysis after excluding patients without DM-related laboratory parameters, those who declined to participate through the institutional opt-out procedure, pediatric patients, and patients with diabetic iritis. DM was defined as an HbA1c level of 6.5% or higher, current treatment for DM, or a random blood glucose level of 200 mg/dL or higher. For reference comparisons with national data, we analyzed seven adult entities with sufficient sample size. For each entity, expected DM prevalence was based on the corresponding national age-stratum estimate according to the mean age category of that entity. Observed and expected DM prevalence estimates were compared using Fisher's exact test. Multivariable modified Poisson regression with robust variance estimation was used to estimate adjusted prevalence ratios (aPRs) for DM prevalence, including age, sex, and individual uveitis entities as covariates. Overall, 166 of 3163 patients (5.3%) had DM. DM prevalence differed substantially by etiology, ranging from 18.0% in endophthalmitis to 1.8% in Behçet disease. Selected infectious uveitis showed a higher crude prevalence of DM than selected noninfectious uveitis (10.4% vs. 3.8%;

Indexed as

Behçet diseasediabetes mellitusinfectious uveitisnational prevalence estimatesprevalencesarcoidosisuveitis

Identifiers

PMID42449829
PMCPMC13359844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.